Men over 65 tend to get prostate cancer, the second leading cause of cancer death among American men. Fairfield University looked at research of early stage prostate cancer among older men and whether "watchful waiting" was a reasonable option to aggressive therapy. Health care providers are divided regarding the best treatment options for prostate cancer and, with no definitive agreement; diagnosed men tend to experience more uncertainty in making treatment decisions. One thing is certain, further work is needed to change the perception that delaying treatment, which may actually be the best option in many cases, is an automatic death sentence.
"Publishing research that can positively affect men's health is the focus of American Journal of Men's Health," commented the journal's editor, Demetrius Porche, DNS, APRN. "These two studies exploring men's cancers illustrate that mission and are examples of the types of cutting-edge information each issue will feature."
The article, "Critical Review: Is Watchful Waiting a Viable Management Option for Older Men with Prostate Cancer?," written by Donald E. Bailey Jr., PhD, RN, and Meredith Wallace, PhD, APRN, BC can be accessed free for a limited time at http://jmh.sagepub.com/cgi/reprint/1/1/18